Feedback / Questions
AU-007 - Aulos Biosci
https://www.businesswire.com/news/home/20221031005230/en/Aulos-Bioscience-Announces-FDA-Clearance-of-IND-Application-for-AU-007-a-Novel-Immunotherapy-for-the-Treatment-of-Solid-Tumors
Oct 31, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next